Hydroxamic acid compounds
CA 2196845 C · Owner: Ito, Fumitaka · Inventors: Ito, Fumitaka
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A compound of the following formula:, (see fig. I) and its pharmaceutically acceptable salt thereof wherein, R1 and R~ are independently hydrogen C1-4 alkyl, C3-7 cycloalkyl, C2-4 alkenyl,C1-4 alkoxy-C1-4 alkyl C1-4 alkylthio-C1-4 alkyl, phenyl, phenyl-C1-4alkyl halo-substituted C1-4 alkyl, C3-7 cycloalkyl-C1-3 alkyl or hydroxy-C1-4alkyl; or R1 and R~ are taken together with the nitrogen to which they are attached and form optionally substituted, saturated or unsaturated 3- 4-, 5-, 6- or 7- membered, heterocyclic containing one to two heteroatoms provided that the heterocyclic, is not pyrrolidinyl; R3 is hydrogen, C1-4 alkyl or a hydroxy protecting group; Ar is optionally substituted phenyl …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 5, 1997 and granted August 21, 2001. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended February 5, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 5, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.